A detailed history of Golden State Equity Partners transactions in Boston Scientific Corp stock. As of the latest transaction made, Golden State Equity Partners holds 10,463 shares of BSX stock, worth $871,672. This represents 0.17% of its overall portfolio holdings.

Number of Shares
10,463
Holding current value
$871,672
% of portfolio
0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

BUY
$67.33 - $77.71 $704,473 - $813,079
10,463 New
10,463 $805,000
Q1 2022

May 16, 2022

BUY
$40.9 - $45.1 $352,067 - $388,220
8,608 New
8,608 $333,000
Q2 2021

Aug 12, 2021

SELL
$38.58 - $44.24 $332,096 - $380,817
-8,608 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$35.27 - $39.67 $11,039 - $12,416
313 Added 3.77%
8,608 $333,000
Q4 2020

Feb 08, 2021

BUY
$33.15 - $41.97 $274,979 - $348,141
8,295 New
8,295 $298,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $119B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Golden State Equity Partners Portfolio

Follow Golden State Equity Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

News

Stay updated on Golden State Equity Partners with notifications on news.